Developer docs
API playgroundTry for free, no card

Search company profiles

Creative Diagnostics

Full company profile

uuid0003nkq

Namestring
Creative Diagnostics
Legal namestring
Creative Diagnostics
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Creative Diagnostics is a privately held New York-based biotechnology company founded in 2005 that manufactures and supplies antibodies, antigens, ELISA kits, rapid test kits, hybridomas, and related reagents to life science research and in vitro diagnostics (IVD) customers. The company serves pharmaceutical and biotechnology firms, IVD manufacturers, academic research institutions, food safety laboratories, and veterinary diagnostic organizations across more than 40 countries, with contact offices in the United States (Long Island, NY) and the United Kingdom (Manchester).

The product and technology stack centers on antibody and antigen development built around proprietary platforms including Magic Hybridoma™, Omni-Hybridoma™, and MPAT™ for antibody discovery, the HiResNb™/VHH nanobody platform, the MemND™ nanodisc system for membrane protein research, and the Magic™ adjuvant family. Creative Diagnostics maintains a catalog exceeding 80,000 primary antibodies across more than 14,000 targets, complemented by a services portfolio spanning antigen generation, custom antibody production (monoclonal, polyclonal, VHH, anti-idiotype, phospho-specific), contract assay development (ELISA, lateral flow, chemiluminescent immunoassay), immunocytochemistry, analytical services (anti-drug antibody assays, epitope mapping, biomolecular interaction analysis, SARS-CoV-2 pseudovirus neutralization, ADC PK assays), immunoprecipitation, and subcellular fractions for ADME studies. Most recent capability additions include an AI-assisted protein engineering service and an integrated AI-powered CRO platform for infectious disease drug discovery launched in February 2026.

Revenue is generated through three channels — catalog reagent sales, custom development and analytical services, and IVD raw material supply — all conducted on a quote-based pricing model with sales inquiries responded to within 24 hours. Go-to-market combines direct sales through the company's e-commerce inquiry platform, a global distributor network, and event-driven engagement at major industry conferences (MEDICA, ADLM, ASM Microbe). The company is consistently launching new products: 2024 saw Rapid Robenidine Test Reagents for poultry food safety; 2025 brought VHH reagents for swine disease, ADME/Renal Metabolism lines, dengue virus mouse models, Respiratory Syncytial Virus Antigens, and the CDJCV™ Anti-polyomavirus JC IgG ELISA Kit; 2026 has added the AI-powered CRO platform, subcellular fractions for renal metabolism, and equine disease detection reagents. The company is recognized as a top-five player in the chloramphenicol test kits market and operates without disclosed venture capital or private equity backing.

Short descriptiontext

Creative Diagnostics is a privately held New York-based biotech company that manufactures antibodies, antigens, ELISA kits, rapid test kits, and custom assay services for pharmaceutical, IVD, academic, veterinary, and food safety customers across more than 40 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
antibody manufacturing, antigen reagents, ELISA kits, custom antibody development, in vitro diagnostics
Industry4 codes
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAAAIAB
Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Scientific Research and Development Services5417
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Life Science Reagents and Diagnostic Antibodies
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Research-use Antibodies and Antigens
TypeOne Time License
Description

Sale of research-use antibodies, antigens, ELISA kits, and reagents to pharmaceutical companies, biotechnology companies, diagnostic manufacturers, and academic research institutions worldwide.

creative-diagnostics.com
2Custom Services
TypeProfessional Services
Description

Contract research services including custom antibody development, assay development, and analytical services for drug discovery and development.

creative-diagnostics.com
3IVD Raw Materials
TypeOne Time License
Description

Supply of immunodiagnostic raw materials including high-quality antibodies and antigens for assay development to IVD and life science companies.

creative-diagnostics.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
Pricing details1 tier
1B2B quote-based pricing
ModelOtherBilling cadencePay-as-you-go
Notes

Creative Diagnostics operates on a quote-based pricing model for all products and services. No public pricing listed on website. Contact: 1-631-624-4882 (USA), 44-161-818-6441 (Europe), info@creative-diagnostics.com

creative-diagnostics.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 10 records shown
1HiResNb™
Description

Nano secondary antibodies (Nanobodies/VHHs) for research applications, including recombinant alpaca anti-Rabbit and anti-Mouse IgG antibodies with various conjugates

creative-diagnostics.com
+9 more records
Core offering1 text field

Creative Diagnostics manufactures and supplies antibodies, antigens, ELISA kits, rapid test kits, and hybridoma cell lines for life science research and in vitro diagnostics. It also operates a custom services arm covering antigen generation, antibody generation (including VHH/nanobodies and DNA/LNP-mRNA platforms), contract assay development (ELISA, CLIA, lateral flow), immunocytochemistry, analytical bioanalytical services, and immunoprecipitation services, supported by an AI-powered integrated CRO platform for infectious disease drug discovery.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Reduces antibody development time through proprietary Magic™ Adjuvant formulation requiring fewer immunizations and less antigen dosage
+1 more record
Product overview1 text field

Creative Diagnostics is a New York-based manufacturer and supplier of antibodies, antigens, and assay kits for the IVD and life science communities. The product portfolio centers on immunoassay reagents organized around core product categories: Antibodies (primary, secondary, and control antibodies including monoclonal, polyclonal, and recombinant formats), Antigens (viral, bacterial, fungal, parasitic antigens, synthetic peptides, and VLP-displayed antigens), ELISA Kits (autoimmune, cardiac, cytokine, food safety, infectious disease, hormone, and tumor marker kits), Rapid Test Kits, Materials and Reagents (adjuvants, conjugation kits, ECL substrates), and Hybridomas. The portfolio includes branded products such as Magic™ Adjuvant, HiResNb™ Secondary VHH Antibodies, and CDSimple™ Chemiluminescent ELISA Kits. Services are organized as a separate offerings layer covering Antigen Generation, Antibody Generation (including VHH production), Contract Assay Development, Immunocytochemistry, Analytical Services, and Immunoprecipitation Services. Technical platforms support both Antibody Discovery & Development (B Cell Sorting, Hybridoma platforms, MPAT™) and IVD assay development (CLIA, LFIA, ELISA). The company also offers an AI-powered integrated CRO platform for infectious disease drug discovery.

Product and service18 records
1Antibodies (Primary, Secondary, Control)
CategoryAntibodies
Description

High-quality antibodies including monoclonal, polyclonal, and recombinant primary antibodies (80,000+ against 14,000+ targets), species-specific secondary antibodies with various conjugated labels, and control antibodies (anti-Tubulin, GAPDH, β-Actin, Histone H3) for Western blot, immunoprecipitation, immunofluorescence, and ELISA; sold to research and IVD laboratories.

2Antigens (Viral, Bacterial, Fungal, Parasitic)
CategoryAntigens
Description

Catalog of viral, bacterial, fungal, and parasitic antigens, plus synthetic peptides, blocking peptides, recombinant proteins, VLP-displayed antigens, autoantigens, cytokines and hormones antigens, cancer biomarker antigens, cardiac biomarkers, allergens, and neurodegeneration antigens; used by vaccine, immunology, and infectious disease researchers.

3ELISA Kits
CategoryELISA Kits
Description

ELISA kits covering autoimmune, cardiac markers, cytokines, food safety, infectious disease, hormone markers, tumor markers, and specialty analytes, including high-sensitivity chemiluminescent CDSimple™ kits; sold to clinical, food safety, and research laboratories.

4Rapid Test Kits
CategoryRapid Diagnostic Test Kits
Description

Point-of-care rapid diagnostic test kits for applications including food safety (e.g., chloramphenicol residue testing, Rapid Robenidine Test Reagents for poultry) and infectious disease screening; sold to food testing laboratories and veterinary/poultry diagnostics customers.

5Materials and Reagents (including Magic™ Adjuvant, ECL substrates, conjugation kits)
CategoryLab Reagents and Consumables
Description

Adjuvants (Magic™ Adjuvant, Magic™ Camelid Adjuvant), antibody conjugation kits, ECL substrates, Magic-Fluor™ mIHC Staining Kits, cell freezing media, antibody isotyping kits, recombinant virus protein test kits, lentivirus titer kits, N-glycan analysis kits, and active pre-formed fibrils; sold as ancillary reagents to antibody and assay development laboratories.

6Hybridomas
CategoryCell Lines
Description

Hybridoma cell lines (mouse, rat, hamster, and heterohybridoma) used to produce monoclonal antibodies, including IHC-positive screening services; supplied to research and industrial antibody production customers.

7Antigen Generation Services
CategoryCustom Services
Description

Custom antigen generation services covering protein antigen expression, peptide antigen synthesis and conjugation, antigen retrieval services, the MemND™ Nanodisc system for membrane protein antigens, AI-assisted protein engineering, and Avi-tag site-specific biotinylation; performed for pharma, biotech, and academic clients.

8Antibody Generation Services
CategoryCustom Antibody Development
Description

Custom antibody development services including monoclonal, polyclonal, anti-idiotype, anti-hapten, transmembrane, phospho-specific, VHH/nanobody, DNA immunization, LNP-mRNA-based, RIMMS, and Quenchbody antibody production, plus antibody modification (labeling, fragmentation, purification, hybridoma optimization, scale-up); provided to pharma, biotech, and academic customers.

9Contract Assay Development
CategoryAssay Development Services
Description

Contract development of ELISA kits, colloidal gold lateral flow strips, chemiluminescent immunoassays, virus-like particle antigens, and pharmaceutical/diagnostic testing platforms (allergen and autoimmune disease analysis); offered to IVD manufacturers and research customers.

10Analytical Services
CategoryBioanalytical Services
Description

Bioanalytical services for biologics and vaccine development, including anti-drug antibody assays, epitope mapping, biomolecular interaction analysis, SARS-CoV-2 pseudovirus neutralization and ADE assays, PK assays for ADCs, and custom cellular biosensors for ligand-receptor interaction studies; supplied to pharma and biotech developers.

11Immunoprecipitation Services
CategoryCustom Services
Description

Immunoprecipitation services including Co-IP/MS, tandem affinity purification/MS (TAP/MS), chromatin immunoprecipitation (ChIP), RNA immunoprecipitation (RIP), cross-linking and immunoprecipitation (CLIP), and standard IP; provided to academic and industry research groups studying protein interactions and chromatin.

12Equine Diseases Detection Reagents
CategoryVeterinary Diagnostic Reagents
Description

Reagents for detecting equine infectious anemia virus (EIAV), equine influenza virus (EIV), and equine arteritis virus (EAV) in horses, validated for ELISA, Western blotting, and immunofluorescence assays; targeted at veterinary diagnostics and equine surveillance laboratories.

13Products for Renal Metabolism
CategoryADME and Drug Metabolism Reagents
Description

Subcellular fractions (kidney microsomes and cytosol) from human, non-human primate, beagle dog, minipig, and rodent species, used by pharmaceutical researchers and toxicologists for in vitro drug metabolism and ADME studies.

14Integrated CRO Platform for AI-Powered Infectious Disease Drug Discovery
CategoryCRO Services Platform
Description

AI-powered integrated CRO service platform that combines molecular modeling, virtual screening, and data analysis to help biotech and pharmaceutical researchers identify lead compounds for infectious diseases faster than conventional methods, from target identification through candidate optimization.

15CDJCV™ Anti-polyomavirus JC IgG ELISA Kit
CategoryELISA Kits
Description

ELISA kit for detecting JC polyomavirus IgG antibodies in human serum, intended to aid research into JCV-related diseases including progressive multifocal leukoencephalopathy (PML); targeted at clinical and translational research laboratories.

16VHH Reagents and Antigens for Swine Disease Detection
CategoryVeterinary Diagnostic Reagents
Description

VHH (nanobody) reagents and antigens for rapid diagnosis of porcine reproductive and respiratory syndrome virus (PRRSV) and related swine viruses, supporting competitive ELISAs and immunofluorescence tests; targeted at veterinary and livestock diagnostics laboratories.

17Respiratory Syncytial Virus Antigens
CategoryViral Antigens
Description

Antigen product line covering key Respiratory Syncytial Virus proteins from subgroups A and B, used in RSV diagnostics, vaccine development, and virological studies by research and vaccine developer customers.

18Dengue Virus Mouse Models
CategoryAnimal Disease Models
Description

Validated mouse models for dengue virus (DENV) research that mimic human infection symptoms and immune responses, used to study DENV pathogenesis and develop antiviral drugs and vaccines across multiple serotypes and strains.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeOthers
Description

Creative Diagnostics is identified as a top company in the Hantavirus Diagnostics Market (2026-2033) in a market research report, indicating recognition within the industry analyst community.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

GenScript is a direct competitor offering custom antibody development, recombinant antibody production, and an extensive catalog of research-use antibodies — directly overlapping Creative Diagnostics' core custom services and catalog business across pharma/biotech and academic customers.

TypeDirect peer
Description

Abcam is the largest catalog antibody supplier globally with over 100,000 products targeting similar applications (WB, ELISA, IHC, FC). It is a primary direct competitor to Creative Diagnostics in the same research-use antibody and reagent category serving the same pharma/biotech/academic customer base.

TypeDirect peer
Description

Cell Signaling Technology offers high-validity antibodies (especially phospho-specific and signaling-pathway targets) with strong validation data — directly competing with Creative Diagnostics' catalog in research antibody applications and overlapping on cancer and cell biology research areas.

TypeDirect peer
Description

Novus Biologicals, part of Bio-Techne, is a direct competitor supplying primary antibodies, ELISA kits, and reagents to the same life science research customer base, with comparable catalog breadth across thousands of targets.

5Santa Cruz Biotechnology
TypeDirect peer
Description

Santa Cruz Biotechnology is a long-established research antibody supplier offering monoclonal and polyclonal antibodies across broad research applications, directly competing with Creative Diagnostics' catalog antibodies in academic and pharma research markets.

TypeDirect peer
Description

Rockland Immunochemicals manufactures antibodies, ELISA kits, and immunochemical reagents with custom antibody services, directly overlapping Creative Diagnostics' custom antibody production and catalog reagent offering for research and IVD customers.

7ProSci Incorporated
TypeDirect peer
Description

ProSci is a specialty custom antibody and immunoassay service provider offering polyclonal, monoclonal, and affinity purification services — directly comparable to Creative Diagnostics' custom antibody development, analytical, and immunoprecipitation service offerings.

TypeDirect peer
Description

Jackson ImmunoResearch specializes in secondary antibodies and antibody conjugates used in life science research — directly comparable to Creative Diagnostics' secondary antibody portfolio including the HiResNb™ VHH nano-secondary line.

TypeBroad incumbent
Description

Bio-Rad is a broad life-science tools incumbent offering antibodies, ELISA kits, protein electrophoresis, and clinical diagnostics products across its portfolio — overlapping Creative Diagnostics' catalog reagents and IVD-adjacent offerings but as one of many product lines.

TypeBroad incumbent
Description

PerkinElmer/Revvity is a broad incumbent in life sciences and diagnostics with companion food-safety testing capabilities — listed alongside Creative Diagnostics as a top 5 player in the chloramphenicol test kits market and active in similar IVD assay reagent categories.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Creative Diagnostics

Life Science Reagents and Diagnostic Antibodiescreative-diagnostics.com

Creative Diagnostics is a privately held New York-based biotech company that manufactures antibodies, antigens, ELISA kits, rapid test kits, and custom assay services for pharmaceutical, IVD, academic, veterinary, and food safety customers across more than 40 countries.

What Creative Diagnostics does

Creative Diagnostics is a privately held New York-based biotechnology company founded in 2005 that manufactures and supplies antibodies, antigens, ELISA kits, rapid test kits, hybridomas, and related reagents to life science research and in vitro diagnostics (IVD) customers. The company serves pharmaceutical and biotechnology firms, IVD manufacturers, academic research institutions, food safety laboratories, and veterinary diagnostic organizations across more than 40 countries, with contact offices in the United States (Long Island, NY) and the United Kingdom (Manchester).

The product and technology stack centers on antibody and antigen development built around proprietary platforms including Magic Hybridoma™, Omni-Hybridoma™, and MPAT™ for antibody discovery, the HiResNb™/VHH nanobody platform, the MemND™ nanodisc system for membrane protein research, and the Magic™ adjuvant family. Creative Diagnostics maintains a catalog exceeding 80,000 primary antibodies across more than 14,000 targets, complemented by a services portfolio spanning antigen generation, custom antibody production (monoclonal, polyclonal, VHH, anti-idiotype, phospho-specific), contract assay development (ELISA, lateral flow, chemiluminescent immunoassay), immunocytochemistry, analytical services (anti-drug antibody assays, epitope mapping, biomolecular interaction analysis, SARS-CoV-2 pseudovirus neutralization, ADC PK assays), immunoprecipitation, and subcellular fractions for ADME studies. Most recent capability additions include an AI-assisted protein engineering service and an integrated AI-powered CRO platform for infectious disease drug discovery launched in February 2026.

Revenue is generated through three channels — catalog reagent sales, custom development and analytical services, and IVD raw material supply — all conducted on a quote-based pricing model with sales inquiries responded to within 24 hours. Go-to-market combines direct sales through the company's e-commerce inquiry platform, a global distributor network, and event-driven engagement at major industry conferences (MEDICA, ADLM, ASM Microbe). The company is consistently launching new products: 2024 saw Rapid Robenidine Test Reagents for poultry food safety; 2025 brought VHH reagents for swine disease, ADME/Renal Metabolism lines, dengue virus mouse models, Respiratory Syncytial Virus Antigens, and the CDJCV™ Anti-polyomavirus JC IgG ELISA Kit; 2026 has added the AI-powered CRO platform, subcellular fractions for renal metabolism, and equine disease detection reagents. The company is recognized as a top-five player in the chloramphenicol test kits market and operates without disclosed venture capital or private equity backing.

Creative Diagnostics firmographics

Firmographics
Name
Creative Diagnostics
Legal name
Creative Diagnostics
Website
https://creative-diagnostics.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
1–10 employees
Short description
Creative Diagnostics is a privately held New York-based biotech company that manufactures antibodies, antigens, ELISA kits, rapid test kits, and custom assay services for pharmaceutical, IVD, academic, veterinary, and food safety customers across more than 40 countries.
Ownership category
akta.pro rank

Creative Diagnostics industry classification

Industry
Product category
Life Science Reagents and Diagnostic Antibodies
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Scientific Research and Development Services (5417)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAAAIAB
Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Antibody manufacturing
  • Antigen reagents
  • ELISA kits
  • Custom antibody development
  • In vitro diagnostics

Where Creative Diagnostics is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Creative Diagnostics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Research-use Antibodies and Antigens: Sale of research-use antibodies, antigens, ELISA kits, and reagents to pharmaceutical companies, biotechnology companies, diagnostic manufacturers, and academic research institutions worldwide.
  2. Custom Services: Contract research services including custom antibody development, assay development, and analytical services for drug discovery and development.
  3. IVD Raw Materials: Supply of immunodiagnostic raw materials including high-quality antibodies and antigens for assay development to IVD and life science companies.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goB2B quote-based pricing

Go-to-market motion3 records

Distribution channels2 records

Marketing channels4 records

Creative Diagnostics product offering

Product offering

Core offering

Creative Diagnostics manufactures and supplies antibodies, antigens, ELISA kits, rapid test kits, and hybridoma cell lines for life science research and in vitro diagnostics. It also operates a custom services arm covering antigen generation, antibody generation (including VHH/nanobodies and DNA/LNP-mRNA platforms), contract assay development (ELISA, CLIA, lateral flow), immunocytochemistry, analytical bioanalytical services, and immunoprecipitation services, supported by an AI-powered integrated CRO platform for infectious disease drug discovery.

Product overview

Creative Diagnostics is a New York-based manufacturer and supplier of antibodies, antigens, and assay kits for the IVD and life science communities. The product portfolio centers on immunoassay reagents organized around core product categories: Antibodies (primary, secondary, and control antibodies including monoclonal, polyclonal, and recombinant formats), Antigens (viral, bacterial, fungal, parasitic antigens, synthetic peptides, and VLP-displayed antigens), ELISA Kits (autoimmune, cardiac, cytokine, food safety, infectious disease, hormone, and tumor marker kits), Rapid Test Kits, Materials and Reagents (adjuvants, conjugation kits, ECL substrates), and Hybridomas. The portfolio includes branded products such as Magic™ Adjuvant, HiResNb™ Secondary VHH Antibodies, and CDSimple™ Chemiluminescent ELISA Kits. Services are organized as a separate offerings layer covering Antigen Generation, Antibody Generation (including VHH production), Contract Assay Development, Immunocytochemistry, Analytical Services, and Immunoprecipitation Services. Technical platforms support both Antibody Discovery & Development (B Cell Sorting, Hybridoma platforms, MPAT™) and IVD assay development (CLIA, LFIA, ELISA). The company also offers an AI-powered integrated CRO platform for infectious disease drug discovery.

Differentiator

Problem solved

Functional benefit

Brands

  • HiResNb™: Nano secondary antibodies (Nanobodies/VHHs) for research applications, including recombinant alpaca anti-Rabbit and anti-Mouse IgG antibodies with various conjugates
  • CDSimple™
  • Magic™
  • RapidGet™
  • CDJCV™
  • RHA™
  • MemND™
  • Magic Hybridoma™
  • Omni-Hybridoma™
  • MPAT™

Products and services

  • Antibodies (Primary, Secondary, Control) High-quality antibodies including monoclonal, polyclonal, and recombinant primary antibodies (80,000+ against 14,000+ targets), species-specific secondary antibodies with various conjugated labels, and control antibodies (anti-Tubulin, GAPDH, β-Actin, Histone H3) for Western blot, immunoprecipitation, immunofluorescence, and ELISA; sold to research and IVD laboratories.
  • Antigens (Viral, Bacterial, Fungal, Parasitic) Catalog of viral, bacterial, fungal, and parasitic antigens, plus synthetic peptides, blocking peptides, recombinant proteins, VLP-displayed antigens, autoantigens, cytokines and hormones antigens, cancer biomarker antigens, cardiac biomarkers, allergens, and neurodegeneration antigens; used by vaccine, immunology, and infectious disease researchers.
  • ELISA Kits ELISA kits covering autoimmune, cardiac markers, cytokines, food safety, infectious disease, hormone markers, tumor markers, and specialty analytes, including high-sensitivity chemiluminescent CDSimple™ kits; sold to clinical, food safety, and research laboratories.
  • Rapid Test Kits Point-of-care rapid diagnostic test kits for applications including food safety (e.g., chloramphenicol residue testing, Rapid Robenidine Test Reagents for poultry) and infectious disease screening; sold to food testing laboratories and veterinary/poultry diagnostics customers.
  • Materials and Reagents (including Magic™ Adjuvant, ECL substrates, conjugation kits) Adjuvants (Magic™ Adjuvant, Magic™ Camelid Adjuvant), antibody conjugation kits, ECL substrates, Magic-Fluor™ mIHC Staining Kits, cell freezing media, antibody isotyping kits, recombinant virus protein test kits, lentivirus titer kits, N-glycan analysis kits, and active pre-formed fibrils; sold as ancillary reagents to antibody and assay development laboratories.
  • Hybridomas Hybridoma cell lines (mouse, rat, hamster, and heterohybridoma) used to produce monoclonal antibodies, including IHC-positive screening services; supplied to research and industrial antibody production customers.
  • Antigen Generation Services Custom antigen generation services covering protein antigen expression, peptide antigen synthesis and conjugation, antigen retrieval services, the MemND™ Nanodisc system for membrane protein antigens, AI-assisted protein engineering, and Avi-tag site-specific biotinylation; performed for pharma, biotech, and academic clients.
  • Antibody Generation Services Custom antibody development services including monoclonal, polyclonal, anti-idiotype, anti-hapten, transmembrane, phospho-specific, VHH/nanobody, DNA immunization, LNP-mRNA-based, RIMMS, and Quenchbody antibody production, plus antibody modification (labeling, fragmentation, purification, hybridoma optimization, scale-up); provided to pharma, biotech, and academic customers.
  • Contract Assay Development Contract development of ELISA kits, colloidal gold lateral flow strips, chemiluminescent immunoassays, virus-like particle antigens, and pharmaceutical/diagnostic testing platforms (allergen and autoimmune disease analysis); offered to IVD manufacturers and research customers.
  • Analytical Services Bioanalytical services for biologics and vaccine development, including anti-drug antibody assays, epitope mapping, biomolecular interaction analysis, SARS-CoV-2 pseudovirus neutralization and ADE assays, PK assays for ADCs, and custom cellular biosensors for ligand-receptor interaction studies; supplied to pharma and biotech developers.
  • Immunoprecipitation Services Immunoprecipitation services including Co-IP/MS, tandem affinity purification/MS (TAP/MS), chromatin immunoprecipitation (ChIP), RNA immunoprecipitation (RIP), cross-linking and immunoprecipitation (CLIP), and standard IP; provided to academic and industry research groups studying protein interactions and chromatin.
  • Equine Diseases Detection Reagents Reagents for detecting equine infectious anemia virus (EIAV), equine influenza virus (EIV), and equine arteritis virus (EAV) in horses, validated for ELISA, Western blotting, and immunofluorescence assays; targeted at veterinary diagnostics and equine surveillance laboratories.
  • Products for Renal Metabolism Subcellular fractions (kidney microsomes and cytosol) from human, non-human primate, beagle dog, minipig, and rodent species, used by pharmaceutical researchers and toxicologists for in vitro drug metabolism and ADME studies.
  • Integrated CRO Platform for AI-Powered Infectious Disease Drug Discovery AI-powered integrated CRO service platform that combines molecular modeling, virtual screening, and data analysis to help biotech and pharmaceutical researchers identify lead compounds for infectious diseases faster than conventional methods, from target identification through candidate optimization.
  • CDJCV™ Anti-polyomavirus JC IgG ELISA Kit ELISA kit for detecting JC polyomavirus IgG antibodies in human serum, intended to aid research into JCV-related diseases including progressive multifocal leukoencephalopathy (PML); targeted at clinical and translational research laboratories.
  • VHH Reagents and Antigens for Swine Disease Detection VHH (nanobody) reagents and antigens for rapid diagnosis of porcine reproductive and respiratory syndrome virus (PRRSV) and related swine viruses, supporting competitive ELISAs and immunofluorescence tests; targeted at veterinary and livestock diagnostics laboratories.
  • Respiratory Syncytial Virus Antigens Antigen product line covering key Respiratory Syncytial Virus proteins from subgroups A and B, used in RSV diagnostics, vaccine development, and virological studies by research and vaccine developer customers.
  • Dengue Virus Mouse Models Validated mouse models for dengue virus (DENV) research that mimic human infection symptoms and immune responses, used to study DENV pathogenesis and develop antiviral drugs and vaccines across multiple serotypes and strains.

Quantifiable outcome

  • Reduces antibody development time through proprietary Magic™ Adjuvant formulation requiring fewer immunizations and less antigen dosage
  • +1 more outcomes

Companies that use Creative Diagnostics

Customer profile

Segments6 records

Ideal customer profiles3 records

Creative Diagnostics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature10 records

Creative Diagnostics partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Market Report Publisher (Market Research Company)minorOthersCreative Diagnostics is identified as a top company in the Hantavirus Diagnostics Market (2026-2033) in a market research report, indicating recognition within the industry analyst community.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Creative Diagnostics competitors and assessment

Company assessment

Direct peers

  • GenScript: GenScript is a direct competitor offering custom antibody development, recombinant antibody production, and an extensive catalog of research-use antibodies — directly overlapping Creative Diagnostics' core custom services and catalog business across pharma/biotech and academic customers.
  • Abcam (Danaher): Abcam is the largest catalog antibody supplier globally with over 100,000 products targeting similar applications (WB, ELISA, IHC, FC). It is a primary direct competitor to Creative Diagnostics in the same research-use antibody and reagent category serving the same pharma/biotech/academic customer base.
  • Cell Signaling Technology: Cell Signaling Technology offers high-validity antibodies (especially phospho-specific and signaling-pathway targets) with strong validation data — directly competing with Creative Diagnostics' catalog in research antibody applications and overlapping on cancer and cell biology research areas.
  • Novus Biologicals (Bio-Techne): Novus Biologicals, part of Bio-Techne, is a direct competitor supplying primary antibodies, ELISA kits, and reagents to the same life science research customer base, with comparable catalog breadth across thousands of targets.
  • Santa Cruz Biotechnology: Santa Cruz Biotechnology is a long-established research antibody supplier offering monoclonal and polyclonal antibodies across broad research applications, directly competing with Creative Diagnostics' catalog antibodies in academic and pharma research markets.
  • Rockland Immunochemicals: Rockland Immunochemicals manufactures antibodies, ELISA kits, and immunochemical reagents with custom antibody services, directly overlapping Creative Diagnostics' custom antibody production and catalog reagent offering for research and IVD customers.
  • ProSci Incorporated: ProSci is a specialty custom antibody and immunoassay service provider offering polyclonal, monoclonal, and affinity purification services — directly comparable to Creative Diagnostics' custom antibody development, analytical, and immunoprecipitation service offerings.
  • Jackson ImmunoResearch: Jackson ImmunoResearch specializes in secondary antibodies and antibody conjugates used in life science research — directly comparable to Creative Diagnostics' secondary antibody portfolio including the HiResNb™ VHH nano-secondary line.

Broad incumbents

  • Bio-Rad Laboratories: Bio-Rad is a broad life-science tools incumbent offering antibodies, ELISA kits, protein electrophoresis, and clinical diagnostics products across its portfolio — overlapping Creative Diagnostics' catalog reagents and IVD-adjacent offerings but as one of many product lines.
  • PerkinElmer (Revvity): PerkinElmer/Revvity is a broad incumbent in life sciences and diagnostics with companion food-safety testing capabilities — listed alongside Creative Diagnostics as a top 5 player in the chloramphenicol test kits market and active in similar IVD assay reagent categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Creative Diagnostics social profiles

Digital presence

Creative Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Creative Diagnostics leadership team

Management profile

Number of profiles

Profiles1 record

Creative Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Creative Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Creative Diagnostics

What does Creative Diagnostics do?

Creative Diagnostics manufactures and supplies antibodies, antigens, ELISA kits, rapid test kits, and hybridoma cell lines for life science research and in vitro diagnostics. It also operates a custom services arm covering antigen generation, antibody generation (including VHH/nanobodies and DNA/LNP-mRNA platforms), contract assay development (ELISA, CLIA, lateral flow), immunocytochemistry, analytical bioanalytical services, and immunoprecipitation services, supported by an AI-powered integrated CRO platform for infectious disease drug discovery.

Is Creative Diagnostics a public or private company?

Creative Diagnostics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Creative Diagnostics founded?

Creative Diagnostics was founded in 2005. It employs 1 to 10 people.

Where is Creative Diagnostics based?

Creative Diagnostics is headquartered in New York, United States, in the North America region.

How does Creative Diagnostics make money?

Three revenue lines are on record. Research-use Antibodies and Antigens are the primary driver. The others are custom Services and IVD Raw Materials.

Who are Creative Diagnostics's main competitors?

Direct peers on record are GenScript, Abcam (Danaher), Cell Signaling Technology, Novus Biologicals (Bio-Techne), Santa Cruz Biotechnology, Rockland Immunochemicals, ProSci Incorporated and Jackson ImmunoResearch. Broad incumbents are Bio-Rad Laboratories and PerkinElmer (Revvity).

Does Creative Diagnostics have an API?

No public API is recorded for Creative Diagnostics.

What industry is Creative Diagnostics in?

Creative Diagnostics's product category is Life Science Reagents and Diagnostic Antibodies. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAGAAAD, Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business & FinancialCreative Diagnostics Introduces High-Risk HPV L1 Virus-Like Particles Produced In Yeast For Research And Assay DevelopmentCreative Diagnostics launched a portfolio of high-risk HPV L1 virus-like particles produced in yeast for research and assay development. The portfolio covers nine genotypes, including HPV16 and HPV18, and provides non-infectious antigens for antibody evaluation and vaccine-related investigations.FinancialContent Business PageCreative Diagnostics Launches Untargeted Metabolomics Services to Accelerate Biomarker Discovery and Metabolic ResearchCreative Diagnostics announced untargeted metabolomics services for research applications, using high-resolution LC-MS/MS to profile metabolites across biological samples. The services support biomarker discovery, drug efficacy assessment, and multi-omics integration, with rigorous quality control procedures.FinancialContent Business PageCreative Diagnostics Launches Comprehensive Dermatophytosis Model Services to Advance Antifungal Drug DevelopmentCreative Diagnostics announced comprehensive Dermatophytosis Model services to support antifungal drug development. The platform offers animal models for dermatophyte infections, including strains like Trichophyton rubrum and various mouse, rabbit, chicken, and guinea pig species. The company aims to accelerate discovery of effective treatment strategies.FinancialContent Business PageCreative Diagnostics Expands Reagent Solutions to Support Outbreak Response Against Bundibugyo VirusCreative Diagnostics announced a range of products and services for the Bundibugyo virus, including antibodies, ELISA and RT-PCR kits, and nucleic acid standards. The company cited a May 2026 WHO report of a fatal outbreak in the DRC, noting no approved vaccines or treatments exist. It aims to support vaccine and diagnostic development.EIN PresswireCreative Diagnostics Introduces Comprehensive Lipidomics Services to Accelerate Biomarker Discovery and Disease ResearchCreative Diagnostics launched specialized lipidomics services based on LC-MS/MS platforms to profile lipids for drug discovery and biomarker research. The service suite covers full-spectrum lipid profiling, quantitative analysis, and bioinformatics, targeting applications in disease diagnosis and translational medicine.EIN PresswireCreative Diagnostics Launches Custom ELISA Kit Development Services for Biopharmaceutical and Diagnostic ResearchCreative Diagnostics launched custom ELISA kit development services for biopharmaceutical and diagnostic research. The services cover antibody screening, microplate coating, and positive control development, aiming to deliver validated kits for specific analytes. The company supports applications from drug discovery to diagnostic biomarker testing.EIN PresswireCreative Diagnostics Launches Respiratory Syncytial Virus Animal Model Services for Antiviral and Vaccine DiscoveryCreative Diagnostics announced a new suite of Respiratory Syncytial Virus animal model services for preclinical testing. The services aim to address host specificity challenges in hRSV research, offering models like cotton rats and mice for evaluating antivirals, antibodies, and vaccines. The company will select models based on each client's research hypotheses.EIN PresswireCreative Diagnostics Launches High-Performance Humanized Control Antibodies to Advance Infectious Disease DiagnosticsCreative Diagnostics launched a new line of humanized control antibodies for infectious disease diagnostics and quality control. The company offers over 200 antibodies covering more than 50 pathogens, produced via recombinant technology to ensure stability and reproducibility. The antibodies are compatible with ELISA, CLIA, and lateral flow assays.EIN PresswireCreative Diagnostics Launches SpeX™ Gerbillinae Liver Microsomes to Advance In Vitro Drug Metabolism ResearchCreative Diagnostics launched SpeX Gerbillinae Liver Microsomes to support drug metabolism research. The microsomes provide an in vitro model using gerbils and sand rats, which have unique metabolic pathways and cerebral vascular anatomy. The model supports studies on cholesterol metabolism, diabetes, neuroprotection, epilepsy, and anti-parasitic drugs.openPR.comMarket Growth Trends, Segment Analysis, and Competitive Strategies Influencing the Poultry Diagnostics IndustryThe poultry diagnostics market is projected to reach $1.11 billion by 2030, growing at a compound annual growth rate of 9.7%, driven by advances in diagnostic technologies, automated devices, and increased focus on preventive healthcare in poultry farming. In March 2024, Netherlands-based HatchTech Group acquired NYtor to strengthen its portfolio in data-driven poultry incubation solutions, while US-based Creative Diagnostics launched Rapid Robenidine Test Reagents in October 2024 to support food safety compliance. Key industry trends include the expanding use of PCR and ELISA-based technologies, rapid point-of-care testing, and integration of diagnostics with digital farm management systems.